Multiple Sclerosis: An Immersive Virtual Patient Simulation

Program Overview

Interact with virtual patients and physicians to learn practical, data-driven strategies that will help you diagnose and treat multiple sclerosis (MS). Take the challenge: Practice managing patients with MS with virtual peers in an interactive, 3D environment. Make decisions and receive conversational feedback from a virtual MS expert, just like in Grand Rounds. Two challenging scenarios include diagnosis, personalized pharmacologic strategies, adherence, how to manage treatment failure, and managing MS in the peripartum setting.

Credit Expired

CE Credit Expired

Expires: October 29, 2020

Target Audience

The target audience for this activity are neurology providers including physicians, as well as NPs and PAs, who diagnose and manage patients with multiple sclerosis (MS).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Diagnose the spectrum of multiple sclerosis (MS), from radiologically isolated syndrome (RIS) to clinically isolated syndrome (CIS) to MS phenotypes using updated diagnostic criteria and the latest expert consensus guidelines
Appropriately initiate and switch available disease-modifying therapies (DMTs) for high-risk CIS and MS on the basis of their efficacy, safety, and tolerability profiles, as well as treatment response, and anticipate the use of novel DMTs in late-phase development
Use shared decision making when prescribing and switching DMTs to promote treatment adherence and positive patient outcomes
Prescribe DMTs in women of child-bearing age on the basis of available DMT safety data, and adjust management according to anticipated changes in disease activity during and after pregnancy

Activity Faculty

Andrew J. Solomon, MD

Associate Professor, Neurological Sciences
Division Chief, Multiple Sclerosis
Larner College of Medicine at The University of Vermont
Burlington, VT

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 